\begin{tabular}{lccccc}
\toprule
Herpesvirus & Direction & AUC (95\% CI) & Cutoff (p-value) & Se & Sp \\
\midrule
CMV         & $\text{controls}>\text{cases}$ & 0.513 (0.398, 0.629) & 196.84 (0.0155) & 0.9000 & 0.000 \\
EBV-EBNA1   & $\text{controls}<\text{cases}$ & 0.584 (0.488, 0.680) & 20.515 (0.0073) & 0.950 & 0.306 \\
EBV-VCA     & $\text{controls}<\text{cases}$ & 0.641 (0.538, 0.744) & 139.235 (0.0073) & 0.650 & 0.643 \\
HHV6        & $\text{controls}<\text{cases}$ & 0.539 (0.427, 0.650) & 148.91 (0.0799) & 0.125 & 0.969 \\
HSV1        & $\text{controls}>\text{cases}$ & 0.626 (0.531, 0.721)\textsuperscript{${\ast}$} & 3.72 (0.0073) & 0.950 & 0.327 \\
HSV2        & $\text{controls}<\text{cases}$ & 0.544 (0.437, 0.650) & 6.875 (0.0799) & 0.550 & 0.633 \\
VZV         & $\text{controls}>\text{cases}$ & 0.573 (0.461, 0.685) & 172.575 (0.0595) & 0.425 & 0.765 \\
\bottomrule
\end{tabular}
% \begin{tblr}{
%     row{1} = {m},
%     column{1} = {l},
%     column{2-5} = {c},
%     hline{1,9} = {-}{0.08em},
%     hline{2} = {-}{0.05em},
% }
% Herpesvirus & Direction & AUC (95\% CI) & Cutoff (p-value) & Se & Sp \\
% CMV         & $\text{controls}>\text{cases}$ & 0.513 (0.398, 0.629) & 196.84 (0.0155) & 0.9000 & 0.000 \\
% EBV-EBNA1   & $\text{controls}<\text{cases}$ & 0.584 (0.488, 0.680) & 20.515 (0.0073) & 0.950 & 0.306 \\
% EBV-VCA     & $\text{controls}<\text{cases}$ & 0.641 (0.538, 0.744) & 139.235 (0.0073) & 0.650 & 0.643 \\
% HHV6        & $\text{controls}<\text{cases}$ & 0.539 (0.427, 0.650) & 148.91 (0.0799) & 0.125 & 0.969 \\
% HSV1        & $\text{controls}>\text{cases}$ & 0.626 (0.531, 0.721)\textsuperscript{${\ast}$} & 3.72 (0.0073) & 0.950 & 0.327 \\
% HSV2        & $\text{controls}<\text{cases}$ & 0.544 (0.437, 0.650) & 6.875 (0.0799) & 0.550 & 0.633 \\
% VZV         & $\text{controls}>\text{cases}$ & 0.573 (0.461, 0.685) & 172.575 (0.0595) & 0.425 & 0.765 \\
% \end{tblr}